Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Therapy × famitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Colorectal Neoplasms 2 Cervical Cancer Metastatic 2 Carcinoma, Renal Cell 2 Thyroid Neoplasms 1 Recurrence 1 Non-squamous Non-small-cell Lung Cancer 1 Non Squamous Non Small Cell Lung 1 Neoplasms 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 NSCLC 1 Gastrointestinal Stromal Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Disease Progression 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 BRCA-Mutated Breast Carcinoma 1 Advanced Solid Tumor 1 Advanced NSCLC 1

Interventions

pembrolizumab 1 pamiparib 1 famitinib 1 enzalutamide 1 apalutamide 1 abiraterone 1 Prednisone 1 Prednisolone 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Neoadjuvant Therapy 1 Folfox protocol 1 Fluorouracil 1 Drug Therapy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06913777 2025-06-06

Neoadjuvant SNF Precision Therapy Phase III

Fudan University

Phase 3 Recruiting

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡